Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicole M. Iovine"'
Autor:
Nicole M. Iovine
Publikováno v:
Virulence
Campylobacter jejuni is a major cause of food-borne gastroenteritis worldwide. While mortality is low, morbidity imparted by post-infectious sequelae such as Guillain-Barré syndrome, Reiter syndrome/reactive arthritis and irritable bowel syndrome is
Autor:
Cornelius J. Clancy, Binghua Hao, Liang Chen, Nicole M. Iovine, Ryan K. Shields, Barry N. Kreiswirth, Ellen G. Press, M. Hong Nguyen
Publikováno v:
Antimicrobial agents and chemotherapy. 59(9)
Avibactam is a novel β-lactamase inhibitor with affinity for Klebsiella pneumoniae carbapenemases (KPCs). In combination with ceftazidime, the agent demonstrates activity against KPC-producing K. pneumoniae (KPC-Kp). KPC-Kp strains are genetically d
Autor:
Nicole M. Iovine, Martin J. Blaser
Publikováno v:
Emerging Infectious Diseases
Emerging Infectious Diseases, Vol 10, Iss 6, Pp 1158-1159 (2004)
Emerging Infectious Diseases, Vol 10, Iss 7, Pp 1346-1346 (2004)
Emerging Infectious Diseases, Vol 10, Iss 6, Pp 1158-1159 (2004)
Emerging Infectious Diseases, Vol 10, Iss 7, Pp 1346-1346 (2004)
Contamination of food with potentially dangerous human pathogens has been recognized since the time of Pasteur (1) and is well-documented in the modern era (2), but the development of antimicrobial agents has helped limit the consequences of such inf
Publikováno v:
Emerging Infectious Diseases, Vol 11, Iss 6, Pp 983-984 (2005)
Emerging Infectious Diseases
Emerging Infectious Diseases
To the Editor: Iovine and Blaser (1) write, "This therapeutic use [of enrofloxacin] was withdrawn (2) but is now under appeal" and "Despite the restrictions on enrofloxacin use, emergence of fluoroquinolone-resistant Campylobacter species, with poult